TY - JOUR KW - Substance Abusers -- Iran KW - Combined Modality Therapy KW - Cognitive Therapy -- Methods KW - Antipsychotic Agents -- therapeutic use KW - Amphetamine KW - Substance Abuse -- Prevention and Control KW - Human KW - Systematic Review KW - Treatment Outcomes KW - Iran KW - MEDLINE KW - PubMed KW - Cochrane Library KW - CINAHL Database KW - Embase KW - Psycinfo KW - Risperidone -- Therapeutic Use KW - Aripiprazole -- Therapeutic Use KW - Topiramate -- Therapeutic Use KW - Methylphenidate -- Therapeutic Use KW - Buprenorphine -- Therapeutic Use KW - Depression -- Prevention and Control KW - Psychotic Disorders -- Prevention and Control KW - Craving -- Prevention and Control KW - Substance Withdrawal Syndrome -- Prevention and Control KW - Methamphetamine KW - Haloperidol -- Therapeutic Use KW - Riluzole -- Therapeutic Use KW - polypharmacy KW - treatment duration KW - Severity of Illness KW - Mental Health KW - Motivation AU - Mansour Khoramizadeh AU - Mohammad Effatpanah AU - Alireza Mostaghimi AU - Mehdi Rezaei AU - Alireza Mahjoub AU - Sara Shishehgar A1 - AD - Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran; School of Medicine, Ziaeian Hospital, Tehran University of Medical Sciences, Tehran, Iran; Student Research Center of International Campus, Tehran University of Medical Sciences, Tehran, Iran; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; Women's and New Born Health Department, Westmead Hospital, Sydney, Australia BT - DARU C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use CY - , DO - 10.1007/s40199-019-00282-3 JF - DARU LA - English M1 - Journal Article PB - Springer Nature PP - , PY - 2019 SN - 1560-8115 SP - 743 EP - 753 EP - T1 - Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern T2 - DARU TI - Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use U3 - 10.1007/s40199-019-00282-3 UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=140157080&site=ehost-live VL - 27 VO - 1560-8115 Y1 - 2019 Y2 - 06/21 ER -